Sign in

CIK 0001706431 · Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
812730369
Phone
415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 4 Grant or award Director acquired 6,405 shares (grant or award)
  2. 4 Grant or award Director acquired 6,405 shares (grant or award)
  3. 4 Grant or award Director acquired 6,405 shares (grant or award)
  4. 4 Grant or award Director acquired 6,405 shares (grant or award)
  5. 4 Open-market sale Director sold 3,374 shares at $23.82 ($80,369)
  6. 4 Grant or award Director acquired 6,405 shares (grant or award)
  7. 4 Grant or award Director acquired 6,405 shares (grant or award)
  8. 4 Grant or award Director acquired 6,405 shares (grant or award)
  9. 4 Open-market sale Director sold 1,687 shares at $23.82 ($40,184)
  10. 8-K Event Shareholder vote results
  11. 8-K Event Material agreement · Agreement ended
  12. 4 Open-market sale Director sold 14,541 shares at $20.62 ($299,835)
  13. 4/A Other acquisition Director acquired 102,041 shares (other)
  14. SC 13D/A Stake Beneficial Ownership Report
  15. 8-K Event Results of operations
  16. 10-Q Report Quarterly Report
  17. 4 Open-market sale Director sold 17,915 shares at an average $20.90 ($374,424)
  18. DEFA14A Proxy Proxy Materials
  19. DEF 14A Proxy Proxy Statement
  20. 8-K Event Executive or director change

Page 22 of 41 · 806 filings